Avanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.41, $0.03 better than the analyst estimate of $0.38. Revenue for the quarter came in at $203 million versus the consensus estimate of $208.28 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2022 EPS of $1.45-$1.65, versus the consensus of $1.64. Avanos Medical, Inc. sees FY2022 revenue of $815-835 million, versus the consensus of $841 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.